MMM Archives - Page 5 of 5 - Blue Horseshoe Stocks

Tenet Healthcare Corp. THC – Options Explode

We included a fresh options trading idea for THC in yesterday morning’s premarket report. The stock was exhibiting the characteristics of a potential bottom bounce play, and we signaled the THC Weekly $18-18.50 Calls to correlate with the possible rebound.

We got just what we were looking for, however, with far greater single-session figured than we could have imagined. The results were two of the best intraday gain possibilities that we’ve identified in 2019, tipping the scales with twenty-bagger status!

$18 Calls – Range: .10-2.14 – Max Gain: 2040%
$18.50 Calls – Range: .05-1.52 – Max Gain: 2940%

Updated Idea: THC Weekly $19.50-20 Calls

PCT Ltd. PCTL

For another quick update on PCTL, the OTC play we’ve been tracking, yesterday the stock registered new highs for the third time this week.

PCTL traded in a range from .017 to .029, for an intraday rip of 71% which also represented a total increase of 226% over our .0089 observed low following our initial alert on Monday morning.

Fresh Options Ideas:
SPY Weekly $301-302 Calls
BUD Weekly $99-101 Calls
MMM Weekly $185-190 Calls

Extended Watchist:
NOK, AZN, MYSZ, FCEL, LPTX, GHDX, UPS, DPW

3M Co. MMM – Update

Fresh for yesterday morning’s report, we decided to highlight some MMM calls on the heels of the company’s earnings report, so we put the MMM Weekly $195-202.50 Calls on the radar.

Thanks to a solid intraday performance wherein the stock ran from a low of 194.20-199.89, there were some huge intraday moves from for traders to take advantage of promptly following the opening bell, which were as follows:

$195 Calls – Range: 2.24-6.00 – Max Gain: 168%
$197.50 Calls – Range: .67-4.34 – Max Gain: 548%
$200 Calls – Range: .71-2.80 – Max Gain: 294%
$202.50 Calls – Range: .27-1.55 – Max Gain: 474%

_____

Fresh Options Ideas:
AAPL Weekly $160-162.50 Calls
SPY Weekly $264-265.50 Calls

TrovaGene, Inc. TROV – Review

We last mentioned TROV on December 18th, and at the time the stock was trading down to an annual low of .503. Since then, we’ve seen a slow and steady recovery, which was kicked into a higher gear yesterday following news of Trovagene and PoC Capital entering an agreement to fund the development of Onvansertib in Metastatic Colorectal Cancer.

The stock ended up hitting .73, marking a 45% rise since we mentioned it. We will want to continue monitoring TROV for further advances from this point forward.

Extended Watchlist:
STAF, CREG, CRMD, EKSO, RGS, CLF, TOPS, WFT, ZYNE, IBN

Tag: MMM

Blue Horseshoe Stocks: THC Explosion

Blue Horseshoe Stocks: MMM Update & More